Liquidia Tightens 340B Contract Pharmacy Restrictions; Biogen, Sanofi Exempt New States
A North Carolina-based drugmaker recently tightened its 340B contract pharmacy restrictions to limit distribution of a pulmonary arterial hypertension treatment—just [...]

